Compounded Semaglutide
Compounded semaglutide is the cash-pay alternative to Wegovy and Ozempic. Compare pricing, safety, and the telehealth brands that ship it.
- Manufacturer
- 503A/503B compounding pharmacies
- Drug class
- GLP-1 receptor agonist (compounded)
- Dose range
- 0.25 mg → 2.5 mg weekly
- Average monthly cost
- $149 – $399 monthly, all-in
- Insurance covered
- No (cash pay only)
Overview
Compounded semaglutide is custom-prepared by licensed pharmacies under FDA section 503A or 503B. It became widely available during the FDA-declared shortage of brand-name semaglutide. As of late 2024 the FDA has begun phasing out the shortage status — compounded supply going forward depends on patient-specific clinical need.
How it works
Same active molecule as Wegovy and Ozempic. The difference is supply chain (compounding pharmacy versus Novo Nordisk) and formulation (often combined with B12 or other additives).
Side effects
- Identical GI profile to brand-name semaglutide
- Additional risk: variability in potency and additives between compounding pharmacies
- Not FDA-reviewed for safety or efficacy as a finished product
Who should consider Compounded Semaglutide
Cash-pay patients who can't access brand-name semaglutide and have discussed compounded options with their prescriber. Verify the pharmacy is licensed and audited.
Telehealth programs that prescribe Compounded Semaglutide
Medvi
Affordable compounded semaglutide & tirzepatide
From $229/mo
TrimRX
Pharmacist-led compounded GLP-1 with concierge support
From $249/mo
Ro (Body)
Brand-name Wegovy & Zepbound through insurance
From $145/mo
Hims & Hers Weight Loss
Mass-market GLP-1 access at consumer pricing
From $199/mo
Mochi Health
Obesity-medicine specialists with insurance navigation
From $79/mo
Found
Behavior-change first, medication when appropriate
From $99/mo
Editorial only — not medical advice. Drug pricing and availability change frequently; verify with the prescribing program before relying on any figure on this page.